Cargando…
A Capped Peptide of the Aggregation Prone NAC 71–82 Amino Acid Stretch of α-Synuclein Folds into Soluble β-Sheet Oligomers at Low and Elevated Peptide Concentrations
Although Lewy bodies and Lewy neurites are hallmarks of Parkinson’s disease (PD) and dementia with Lewy bodies (DLB), misfolded α-synuclein oligomers are nowadays believed to be key for the development of these diseases. Attempts to target soluble misfolded species of the full-length protein have be...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7084662/ https://www.ncbi.nlm.nih.gov/pubmed/32120928 http://dx.doi.org/10.3390/ijms21051629 |
_version_ | 1783508773829083136 |
---|---|
author | Näsström, Thomas Ådén, Jörgen Shibata, Fumina Andersson, Per Ola Karlsson, Björn C.G. |
author_facet | Näsström, Thomas Ådén, Jörgen Shibata, Fumina Andersson, Per Ola Karlsson, Björn C.G. |
author_sort | Näsström, Thomas |
collection | PubMed |
description | Although Lewy bodies and Lewy neurites are hallmarks of Parkinson’s disease (PD) and dementia with Lewy bodies (DLB), misfolded α-synuclein oligomers are nowadays believed to be key for the development of these diseases. Attempts to target soluble misfolded species of the full-length protein have been limited so far, probably due to the fast aggregation kinetics and burial of aggregation prone segments in final cross-β-sheet fibrils. A previous characterisation study of fibrils prepared from a capped peptide of the non-amyloid β-component (NAC) 71–82 amino acid stretch of α-synuclein demonstrated an increased aggregation propensity resulting in a cross-β-structure that is also found in prion proteins. From this, it was suggested that capped NAC 71–82 peptide oligomers would provide interesting motifs with a capacity to regulate disease development. Here, we demonstrated, from a series of circular dichroism spectroscopic measurements and molecular dynamics simulations, the molecular-environment-sensitive behaviour of the capped NAC 71–82 peptide in a solution phase and the formation of β-sheet oligomeric structures in the supernatant of a fibrillisation mixture. These results highlighted the use of the capped NAC 71–82 peptide as a motif in the preparation of oligomeric β-sheet structures that potentially could be used in therapeutic strategies in the fight against progressive neurodegenerative disorders, such as PD and DLB. |
format | Online Article Text |
id | pubmed-7084662 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-70846622020-03-24 A Capped Peptide of the Aggregation Prone NAC 71–82 Amino Acid Stretch of α-Synuclein Folds into Soluble β-Sheet Oligomers at Low and Elevated Peptide Concentrations Näsström, Thomas Ådén, Jörgen Shibata, Fumina Andersson, Per Ola Karlsson, Björn C.G. Int J Mol Sci Article Although Lewy bodies and Lewy neurites are hallmarks of Parkinson’s disease (PD) and dementia with Lewy bodies (DLB), misfolded α-synuclein oligomers are nowadays believed to be key for the development of these diseases. Attempts to target soluble misfolded species of the full-length protein have been limited so far, probably due to the fast aggregation kinetics and burial of aggregation prone segments in final cross-β-sheet fibrils. A previous characterisation study of fibrils prepared from a capped peptide of the non-amyloid β-component (NAC) 71–82 amino acid stretch of α-synuclein demonstrated an increased aggregation propensity resulting in a cross-β-structure that is also found in prion proteins. From this, it was suggested that capped NAC 71–82 peptide oligomers would provide interesting motifs with a capacity to regulate disease development. Here, we demonstrated, from a series of circular dichroism spectroscopic measurements and molecular dynamics simulations, the molecular-environment-sensitive behaviour of the capped NAC 71–82 peptide in a solution phase and the formation of β-sheet oligomeric structures in the supernatant of a fibrillisation mixture. These results highlighted the use of the capped NAC 71–82 peptide as a motif in the preparation of oligomeric β-sheet structures that potentially could be used in therapeutic strategies in the fight against progressive neurodegenerative disorders, such as PD and DLB. MDPI 2020-02-27 /pmc/articles/PMC7084662/ /pubmed/32120928 http://dx.doi.org/10.3390/ijms21051629 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Näsström, Thomas Ådén, Jörgen Shibata, Fumina Andersson, Per Ola Karlsson, Björn C.G. A Capped Peptide of the Aggregation Prone NAC 71–82 Amino Acid Stretch of α-Synuclein Folds into Soluble β-Sheet Oligomers at Low and Elevated Peptide Concentrations |
title | A Capped Peptide of the Aggregation Prone NAC 71–82 Amino Acid Stretch of α-Synuclein Folds into Soluble β-Sheet Oligomers at Low and Elevated Peptide Concentrations |
title_full | A Capped Peptide of the Aggregation Prone NAC 71–82 Amino Acid Stretch of α-Synuclein Folds into Soluble β-Sheet Oligomers at Low and Elevated Peptide Concentrations |
title_fullStr | A Capped Peptide of the Aggregation Prone NAC 71–82 Amino Acid Stretch of α-Synuclein Folds into Soluble β-Sheet Oligomers at Low and Elevated Peptide Concentrations |
title_full_unstemmed | A Capped Peptide of the Aggregation Prone NAC 71–82 Amino Acid Stretch of α-Synuclein Folds into Soluble β-Sheet Oligomers at Low and Elevated Peptide Concentrations |
title_short | A Capped Peptide of the Aggregation Prone NAC 71–82 Amino Acid Stretch of α-Synuclein Folds into Soluble β-Sheet Oligomers at Low and Elevated Peptide Concentrations |
title_sort | capped peptide of the aggregation prone nac 71–82 amino acid stretch of α-synuclein folds into soluble β-sheet oligomers at low and elevated peptide concentrations |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7084662/ https://www.ncbi.nlm.nih.gov/pubmed/32120928 http://dx.doi.org/10.3390/ijms21051629 |
work_keys_str_mv | AT nasstromthomas acappedpeptideoftheaggregationpronenac7182aminoacidstretchofasynucleinfoldsintosolublebsheetoligomersatlowandelevatedpeptideconcentrations AT adenjorgen acappedpeptideoftheaggregationpronenac7182aminoacidstretchofasynucleinfoldsintosolublebsheetoligomersatlowandelevatedpeptideconcentrations AT shibatafumina acappedpeptideoftheaggregationpronenac7182aminoacidstretchofasynucleinfoldsintosolublebsheetoligomersatlowandelevatedpeptideconcentrations AT anderssonperola acappedpeptideoftheaggregationpronenac7182aminoacidstretchofasynucleinfoldsintosolublebsheetoligomersatlowandelevatedpeptideconcentrations AT karlssonbjorncg acappedpeptideoftheaggregationpronenac7182aminoacidstretchofasynucleinfoldsintosolublebsheetoligomersatlowandelevatedpeptideconcentrations AT nasstromthomas cappedpeptideoftheaggregationpronenac7182aminoacidstretchofasynucleinfoldsintosolublebsheetoligomersatlowandelevatedpeptideconcentrations AT adenjorgen cappedpeptideoftheaggregationpronenac7182aminoacidstretchofasynucleinfoldsintosolublebsheetoligomersatlowandelevatedpeptideconcentrations AT shibatafumina cappedpeptideoftheaggregationpronenac7182aminoacidstretchofasynucleinfoldsintosolublebsheetoligomersatlowandelevatedpeptideconcentrations AT anderssonperola cappedpeptideoftheaggregationpronenac7182aminoacidstretchofasynucleinfoldsintosolublebsheetoligomersatlowandelevatedpeptideconcentrations AT karlssonbjorncg cappedpeptideoftheaggregationpronenac7182aminoacidstretchofasynucleinfoldsintosolublebsheetoligomersatlowandelevatedpeptideconcentrations |